Shanghai Xuerong Biotechnology Co.,Ltd. (SHE:300511)
China
· Delayed Price · Currency is CNY 6.68
-0.12 (-1.76%)
At close: Jun 3, 2025, 2:57 PM CST
SHE:300511 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -615.07 | -617.07 | -188.06 | -287.23 | -311.59 | 230.41 | Upgrade
|
| Depreciation & Amortization | 373.92 | 373.92 | 324.76 | 341.34 | 314.26 | 322.32 | Upgrade
|
| Other Amortization | 5.13 | 5.13 | 9.75 | 8.97 | 9.97 | 8.52 | Upgrade
|
| Loss (Gain) From Sale of Assets | -7.85 | -7.85 | 6.46 | 8.42 | 18.4 | 1.68 | Upgrade
|
| Asset Writedown & Restructuring Costs | 428.65 | 428.65 | 62.46 | 402.89 | 194.12 | 28.68 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.65 | 0.65 | 2.65 | -8.87 | -1.01 | -4.01 | Upgrade
|
| Other Operating Activities | 102.28 | 97.82 | 83.21 | -17.7 | 43.66 | 49.57 | Upgrade
|
| Change in Accounts Receivable | 11.8 | 11.8 | 4.74 | 11.16 | -6.06 | 3.71 | Upgrade
|
| Change in Inventory | 73.99 | 73.99 | -58.19 | -89.3 | -57.64 | -63.86 | Upgrade
|
| Change in Accounts Payable | 70.16 | 70.16 | 115.93 | 9.04 | 43.3 | -37.33 | Upgrade
|
| Change in Other Net Operating Assets | - | - | -5.87 | -24.41 | 1.67 | 19.02 | Upgrade
|
| Operating Cash Flow | 443.66 | 437.2 | 357.84 | 367.13 | 244.06 | 555.47 | Upgrade
|
| Operating Cash Flow Growth | 212.07% | 22.18% | -2.53% | 50.43% | -56.06% | -5.36% | Upgrade
|
| Capital Expenditures | -123.46 | -327.46 | -1,097 | -319.47 | -637.19 | -482.79 | Upgrade
|
| Sale of Property, Plant & Equipment | 10.15 | 18.13 | 69.23 | 88.28 | 60.6 | 8.69 | Upgrade
|
| Divestitures | - | - | - | 78 | - | - | Upgrade
|
| Investment in Securities | 0.42 | - | 271.05 | -272 | -20 | -9.48 | Upgrade
|
| Other Investing Activities | - | - | 1.51 | 1.99 | 1.89 | - | Upgrade
|
| Investing Cash Flow | -112.89 | -309.33 | -755.24 | -423.21 | -594.7 | -523.58 | Upgrade
|
| Short-Term Debt Issued | - | 18 | - | 11.52 | 3.89 | - | Upgrade
|
| Long-Term Debt Issued | - | 1,165 | 1,201 | 910.94 | 927.61 | 926.44 | Upgrade
|
| Total Debt Issued | 445.56 | 1,183 | 1,201 | 922.46 | 931.49 | 926.44 | Upgrade
|
| Long-Term Debt Repaid | - | -1,242 | -902.45 | -1,207 | -914.41 | -942.96 | Upgrade
|
| Net Debt Issued (Repaid) | -862.96 | -58.31 | 299 | -284.12 | 17.09 | -16.52 | Upgrade
|
| Issuance of Common Stock | - | - | - | 386.73 | - | 628.35 | Upgrade
|
| Repurchase of Common Stock | -30.05 | -28 | -13.92 | -20.2 | -1.74 | - | Upgrade
|
| Common Dividends Paid | -62.5 | -67.01 | -60.32 | -58.73 | -102.59 | -115.86 | Upgrade
|
| Other Financing Activities | 20.24 | 16.89 | -20.1 | 43.42 | 18.75 | -34.07 | Upgrade
|
| Financing Cash Flow | -935.27 | -136.42 | 204.65 | 67.1 | -68.5 | 461.9 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.83 | 0.53 | 0.15 | 0.16 | -1.36 | -1.62 | Upgrade
|
| Net Cash Flow | -602.67 | -8.02 | -192.6 | 11.18 | -420.49 | 492.17 | Upgrade
|
| Free Cash Flow | 320.2 | 109.74 | -739.19 | 47.66 | -393.13 | 72.68 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | -73.53% | Upgrade
|
| Free Cash Flow Margin | 16.02% | 5.08% | -28.82% | 2.05% | -18.96% | 3.30% | Upgrade
|
| Free Cash Flow Per Share | 0.58 | 0.22 | -1.49 | 0.10 | -0.91 | 0.17 | Upgrade
|
| Cash Income Tax Paid | 26.4 | 26.76 | 21.17 | 22.17 | 19.24 | 15.52 | Upgrade
|
| Levered Free Cash Flow | 280.89 | -46.93 | -490.08 | -63.88 | -654.65 | -53.1 | Upgrade
|
| Unlevered Free Cash Flow | 338.46 | 14.45 | -434.6 | -5.78 | -606.46 | -8.31 | Upgrade
|
| Change in Net Working Capital | -193.36 | -63.96 | -399.32 | 54.18 | 220.94 | 68.75 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.